Trials / Completed
CompletedNCT06792708
Observational Study of LUMRYZ in Narcolepsy
A Prospective, Multicenter, Observational Study of LUMRYZ Used in Clinical Practice for the Treatment of Narcolepsy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 71 (actual)
- Sponsor
- Avadel · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LUMRYZ | Prescribed for narcolepsy in accordance with product label. |
Timeline
- Start date
- 2024-07-18
- Primary completion
- 2025-10-28
- Completion
- 2025-10-28
- First posted
- 2025-01-27
- Last updated
- 2026-02-13
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06792708. Inclusion in this directory is not an endorsement.